Atlas Trials

Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia

Clinical trial NCT01078974 · TERMINATED

Trial details

NCT number
NCT01078974
Sponsor
Steven P. Treon, MD, PhD
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Waldenstrom's Macroglobulinemia
Start date
2010-05-01
Primary completion
2015-09-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.